| 000 | 01422 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518074608.0 | ||
| 264 | 0 | _c20200131 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1536-5964 | ||
| 024 | 7 |
_a10.1097/MD.0000000000018362 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Zun-Yi | |
| 245 | 0 | 0 |
_aResection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis: A systematic review and meta-analysis. _h[electronic resource] |
| 260 |
_bMedicine _cDec 2019 |
||
| 300 |
_ae18362 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Systematic Review | ||
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xmortality |
| 650 | 0 | 4 |
_aChemoembolization, Therapeutic _xmortality |
| 650 | 0 | 4 |
_aConservative Treatment _xmortality |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatectomy _xmortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPortal Vein _xsurgery |
| 650 | 0 | 4 |
_aSorafenib _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVenous Thrombosis |
| 700 | 1 | _aDong, Ke-Shuai | |
| 700 | 1 | _aZhang, Er-Lei | |
| 700 | 1 | _aZhang, Li-Wei | |
| 700 | 1 | _aChen, Xiao-Ping | |
| 700 | 1 | _aDong, Han-Hua | |
| 773 | 0 |
_tMedicine _gvol. 98 _gno. 50 _gp. e18362 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000018362 _zAvailable from publisher's website |
| 999 |
_c30435307 _d30435307 |
||